Bharat Biotech

Bharat Biotech's TB vaccine MTBVAC begins clinical trials in India

By Palak Vaghela 24 Mar 2024 14:35 IST

Business

Bharat Biotech's intranasal covid vaccine priced at ₹325 for govt hospitals

iNCOVACC will also be available on the CoWin platform and will be rolled out in the fourth week of January

By Palak Vaghela 27 Dec 2022 14:26 IST

Share LinkedIn

Health & Fitness

Covaxin cleared for kids aged 6 to 12 years

Bharat Biotech asked to keep submitting safety data

By Palak Vaghela 26 Apr 2022 13:47 IST

Share LinkedIn

Health & Fitness

India gives nod to Bharat Biotech's nasal COVID booster to conduct trials

Hyderabad-based manufacturer Bharat Biotech on Friday was given a go-ahead by the DGCI to conduct trials of its intranasal COVID booster dose in the country.

By Palak Vaghela 28 Jan 2022 16:35 IST

Share LinkedIn

Health & Fitness

Bharat Biotech gets DCGI nod to test nasal COVID-19 vaccine as booster shot

Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday got 'in principle' approval from the country's drug regulator to test nasal COVID-19 vaccine as a booster shot.

By Palak Vaghela 05 Jan 2022 12:24 IST

Share LinkedIn

Health & Fitness

Today begins the COVID-19 vaccination for 15-18 age group

Only Bharat Biotech's 'Covaxin' would be provided in this population segment, according to the Union Health Ministry

By Palak Vaghela 03 Jan 2022 11:09 IST

Share LinkedIn

Health & Fitness

Bharat Biotech's Covaxin will be approved for emergency use by the WHO's Technical Advisory Group today

The technical panel had previously requested further explanations from Bharat Biotech to complete a final risk-benefit analysis for global use of the vaccine.